---
title: "BIOCAUSE HEILEN PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 10.3261 million yuan, a decrease of 72.38%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237695097.md"
description: "BIOCAUSE HEILEN PHARMA released its Q1 2025 performance report, with operating revenue of 114 million yuan, a year-on-year decrease of 17.10%. The net profit attributable to the parent company was 10.3261 million yuan, a year-on-year decline of 72.38%. The net profit after deducting non-recurring gains and losses was 2.5129 million yuan, a year-on-year decrease of 93.03%. The basic earnings per share were 0.04 yuan"
datetime: "2025-04-27T09:01:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237695097.md)
  - [en](https://longbridge.com/en/news/237695097.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237695097.md)
generator: "portal-rs"
---

# BIOCAUSE HEILEN PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 10.3261 million yuan, a decrease of 72.38%

According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) released its first-quarter report for 2025, reporting an operating income of 114 million yuan, a year-on-year decrease of 17.10%. The net profit attributable to shareholders of the listed company was 10.3261 million yuan, a year-on-year decrease of 72.38%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.5129 million yuan, a year-on-year decrease of 93.03%. The basic earnings per share were 0.04 yuan

### Related Stocks

- [301211.CN](https://longbridge.com/en/quote/301211.CN.md)

## Related News & Research

- [Chinese battery firm reports business surge in Morocco](https://longbridge.com/en/news/297265894.md)
- [My Mountain Mover Recognized Among the 2026 Inc. 5000 Fastest-Growing U.S. Companies](https://longbridge.com/en/news/297087696.md)
- [Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners](https://longbridge.com/en/news/296910145.md)
- [Tatneft H1 FY26 net profit rises 205.22% to RR 165.46 billion; revenue increases 15.82% to RR 881.65 billion](https://longbridge.com/en/news/297030202.md)
- [RCS - ZAGENO - ZAGENO and ORO Labs Partnership](https://longbridge.com/en/news/297046609.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**